Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$164.99 - $203.87 $24.7 Million - $30.6 Million
150,000 New
150,000 $26.7 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Adapt Investment Managers Sa Portfolio

Follow Adapt Investment Managers Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adapt Investment Managers Sa, based on Form 13F filings with the SEC.

News

Stay updated on Adapt Investment Managers Sa with notifications on news.